Koyfin Home > Directory > Health Care > Abeona Therapeutics > EV / EBITDA (ntm)

Abeona Therapeutics EV / EBITDA (ntm) Chart (ABEO)

Abeona Therapeutics annual/quarterly EV / EBITDA (ntm) from 2020 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
Other Valuation Metrics:
  • Abeona Therapeutics Market Cap for the quarter ending March 03, 2018 was $678m a 61.98% increase of 420m year over year
  • Abeona Therapeutics Price / Book for the quarter ending March 03, 2018 was 3.96 a 31.95% increase of 1.26 year over year
  • Abeona Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $540m a 63.99% increase of 346m year over year
View Chart On Koyfin